Understanding COVID-19 Pandemic, Impaired Smelling (anosmia) Incidence and Outcome among Patients in Dubai: Retrospective Study
DOI:
https://doi.org/10.54536/ajmsi.v4i1.2979Keywords:
Anosmia, COVID-19, Prevalence, Comorbidities, SymptomsAbstract
The onset of anosmia, or temporary loss of smell, has emerged as a prominent neurological manifestation and an early indicator of COVID-19 infection. This retrospective study, conducted by the Dubai Health Authority (DHA) staff at the DHA COVID-19 Command & Control Center in Dubai – UAE, from May to July 2020, aimed to investigate the prevalence and characteristics of anosmia in COVID-19 patients. A total of 1075 patients were enrolled in the study, comprising 878 males (81.4%) and 201 females (18.6%). The median age ranged from 31 to 40 years. Patients with anosmia were compared to those without, with a particular focus on gender disparities and associated comorbidities, including diabetes, hypertension, heart disease, lung disease, and thyroid disease. The study found that 22% of COVID-19 patients presented with anosmia, the initial symptom in 47% of cases. Notably, 95% of patients experiencing anosmia recovered within two months. While there was no significant correlation between anosmia and comorbidities, such as diabetes, hypertension, heart disease, lung disease, and thyroid disease, there was also no association observed between anosmia and other common COVID-19 symptoms, such as fever, cough, shortness of breath, and diarrhoea. Anosmia, occurring in approximately 22% of COVID-19 cases, is a noteworthy early indicator of the infection. Despite its prevalence, anosmia has no significant correlation with comorbidities or other symptomatic manifestations of COVID-19, which underscores the importance of recognising anosmia as a distinct clinical feature in diagnosing and managing COVID-19.
Downloads
References
Aanand, P., Angral, S., Varshney, S., & Raj, R. (2022). Incidence of Anosmia among Covid 19 patients in India. Indian Journal of Otolaryngology and Head & Neck Surgery, 74(Suppl 2), 3427-3436.
Ahmed, A. K., Sayad, R., Mahmoud, I. A., El-Monem, A. M. A., Badry, S. H., Ibrahim, I. H., Hafez, M. H., El-Mokhtar, M. A., & Sayed, I. M. (2022). Anosmia: The mysterious collateral damage of COVID-19. Journal of Neurovirology, 28(2), 189–200. https://doi.org/10.1007/s13365-022-01060-9
Altundag, A., Saatci, O., Sanli, D. E. T., Duz, O. A., Sanli, A. N., Olmuscelik, O., Temirbekov, D., Kandemirli, S. G., & Karaaltin, A. B. (2021). The temporal course of COVID-19 anosmia and relation to other clinical symptoms. European Archives of Oto-Rhino-Laryngology, 278, 1891-1897.
Avcı, H., Karabulut, B., Farasoglu, A., Boldaz, E., & Evman, M. (2020). Relationship between anosmia and hospitalisation in patients with coronavirus disease 2019: an otolaryngological perspective. The Journal of Laryngology & Otology, 134(8), 710-716.
Beyerstedt, S., Casaro, E. B., & Rangel É, B. (2021). COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis, 40(5), 905-919. https://doi.org/10.1007/s10096-020-04138-6
Butowt, R., & von Bartheld, C. S. (2021). Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. Neuroscientist, 27(6), 582-603. https://doi.org/10.1177/1073858420956905
Daher, V. B., Soares Oliveira, D. S., Daher Júnior, M. F., Júnior de Melo Fernandes, E., Bomtempo de Castro, J. V., Moya, M. I., & de Castro Guimarães, V. (2020). Anosmia: A marker of infection by the new coronavirus. Respiratory Medicine Case Reports, 31, 101129. https://doi.org/10.1016/j.rmcr.2020.101129
de Melo, G. D., Lazarini, F., Levallois, S., Hautefort, C., Michel, V., Larrous, F., Verillaud, B., Aparicio, C., Wagner, S., & Gheusi, G. (2021). COVID-19–related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Science translational medicine, 13(596), eabf8396.
Glezer, I., Bruni-Cardoso, A., Schechtman, D., & Malnic, B. (2021). Viral infection and smell loss: The case of COVID-19. Journal of Neurochemistry, 157(4), 930–943. https://doi.org/10.1111/jnc.15197
Hopkins, C., Surda, P., Whitehead, E., & Kumar, B. N. (2020). Early recovery following new onset anosmia during the COVID-19 pandemic: An observational cohort study. Journal of Otolaryngology Head & Neck Surgery, 49(1), 26. https://doi.org/10.1186/s40463-020-00423-8
Kaye, R., Chang, C. W. D., Kazahaya, K., Brereton, J., & Denneny, J. C., 3rd. (2020). COVID-19 anosmia reporting tool: Initial findings. Otolaryngology Head and Neck Surgery, 163(1), 132–134. https://doi.org/10.1177/0194599820922992
Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., Chekkoury-Idrissi, Y., Hans, S., Delgado, I. L., Calvo-Henriquez, C., Lavigne, P., Falanga, C., Barillari, M. R., Cammaroto, G., Khalife, M., . . . Saussez, S. (2020). Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol, 277(8), 2251-2261. https://doi.org/10.1007/s00405-020-05965-1
Lechien, J. R., Chiesa-Estomba, C. M., Place, S., Van Laethem, Y., Cabaraux, P., Mat, Q., Huet, K., Plzak, J., Horoi, M., Hans, S., Rosaria Barillari, M., Cammaroto, G., Fakhry, N., Martiny, D., Ayad, T., Jouffe, L., Hopkins, C., & Saussez, S. (2020). Clinical and epidemiological characteristics of 1,420 European patients with mild-to-moderate coronavirus disease 2019. Journal of Internal Medicine, 288(3), 335–344. https://doi.org/10.1111/joim.13089
Mastrangelo, A., Bonato, M., & Cinque, P. (2021). Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes. Neuroscience Letters, 748, 135694. https://doi.org/10.1016/j.neulet.2021.135694
Othman, B. A., Maulud, S. Q., Jalal, P. J., Abdulkareem, S. M., Ahmed, J. Q., Dhawan, M., Priyanka, & Choudhary, O. P. (2022). Olfactory dysfunction as a post-infectious symptom of SARS-CoV-2 infection. Ann Med Surg (Lond), 75, 103352. https://doi.org/10.1016/j.amsu.2022.103352
Pollard, C. A., Morran, M. P., & Nestor-Kalinoski, A. L. (2020). The COVID-19 pandemic: a global health crisis. Physiol Genomics, 52(11), 549-557. https://doi.org/10.1152/physiolgenomics.00089.2020
Rebholz, H., Braun, R. J., Ladage, D., Knoll, W., Kleber, C., & Hassel, A. W. (2020). Loss of olfactory function—Early indicator for COVID-19, other viral infections, and neurodegenerative disorders. Frontiers in Neurology, 11, 569333. https://doi.org/10.3389/fneur.2020.569333
Shamsundara, M., & Jayalakshmi, L. (2023). Anosmia—An effect of COVID-19 infection: Review. Indian Journal of Otolaryngology and Head & Neck Surgery, 75(Suppl 1), 815–821. https://doi.org/10.1007/s12070-022-03401-w
Spinato, G., Fabbris, C., Polesel, J., Cazzador, D., Borsetto, D., Hopkins, C., & Boscolo-Rizzo, P. (2020). Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA, 323(20), 2089–2090. https://doi.org/10.1001/jama.2020.6771
Talavera, B., Garcia-Azorin, D., Martinez-Pias, E., Trigo, J., Hernandez-Perez, I., Valle-Penacoba, G., Simon-Campo, P., de Lera, M., Chavarria-Miranda, A., & Lopez-Sanz, C. (2020). Anosmia is associated with lower in-hospital mortality in COVID-19. Journal of the neurological sciences, 419, 117163.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Fateh Almohammad Alsalem
This work is licensed under a Creative Commons Attribution 4.0 International License.
